Rochelle R. Henderson, PhD

Vice President of Research

Rochelle R. Henderson, PhD is Vice President of Research at the National Pharmaceutical Council (NPC). Before joining NPC, Dr. Henderson served as Vice President of Clinical Research at Evernorth, formerly Express Scripts. In this position, she oversaw the strategy and execution of clinical research, including academic and client research portfolio, product and clinical evaluations, and publishing of applied research in peer-reviewed manuscripts. 

During her career, Dr. Henderson has conducted pharmacoepidemiologic and pharmacoeconomic research and focused on the economic evaluation of drug therapy and the impact of plan design on pharmaceutical utilization. Dr. Henderson also has extensive publishing credits, including numerous peer-reviewed articles published in Health Affairs, Value in Health, American Journal of Managed Care, Drug Benefit Trends, Journal of Managed Care Pharmacy, Annals of Pharmacotherapy, Clinical Therapeutics, and other prestigious journals.  

She serves on several health-related research teams with institutions across the St. Louis region: Washington University School of Medicine with Barnes Hospital, the Veteran's Administration Regional Hospital, and the School of Nursing from Southern Illinois University at Edwardsville.  

Dr. Henderson is also an adjunct assistant professor at Washington University School of Medicine. Dr. Henderson received her Ph.D. from the University of Missouri at St. Louis. In addition to publishing numerous health policy papers and making presentations at national and international conferences, she serves with the St. Louis-Samara Sister City Committee. In this capacity, she has hosted international delegations of physicians to the St. Louis area and has visited hospitals and international health care facilities. Dr. Henderson currently serves as Vice-Chair of Blackburn College Board of Trustees. She also served as chairperson of the Friends of the Saint Louis University Liver Research center, which raised funds to support liver research.